Source: The Economic Times, Sept 12, 2017
MUMBAI: At a time when the pharmaceuticals industry is facing the heat with price cuts and regulatory issues in the country, multinational companies are growing faster than their domestic peers due to better product mix, says a study.
While Indian companies still control almost 80% of the Rs 1 lakh crore pharma market in the country, the strategy of launching specialised patented product is helping multinationals grow much faster in India, a report released by market research firm AWACS has said.
While the overall Indian pharma companies registered 1.4% year-on-year growth in August, MNCs clocked 6.2% growth during the month, led by companies such as AstraZeneca, Janssen and Boehringer Ingelheim on the back of their brands Glycomet, Invokana, and Jardiance, respectively, the study said. Read the rest of this entry »